Ehsan Arefian

13PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 06, 2026
Upstream insights for lentiviral vector production: cell platforms, culture parameters, and titer yields.

Pedram Abdollahpour, Alireza Shafizadeh, Ehsan Arefian

|Dec 08, 2025
Broad-Spectrum Antibacterial Activity of Postbiotic From Lacticaseibacillus paracasei BGP1 Against Multidrug-Resistant Skin Wound Pathogens.

Farideh Mohammadhosseinzadeh, Ehsan Arefian, Mouj Khaleghi

|Sep 05, 2023
HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes.

Karrar Mahmood Shaker Al-Khfaji, Nika Kooshki Zamani, Ehsan Arefian

|Oct 11, 2022
The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.

Fatemeh Gheidari, Ehsan Arefian, Fatemeh Saadatpour

|Aug 12, 2022
Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy.

Zahra Fekrirad, Amir Barzegar Behrooz, Shokoofeh Ghaemi

|May 09, 2022
Wnt/β-catenin signaling pathway is involved in early dopaminergic differentiation of trabecular meshwork-derived mesenchymal stem cells.

Faezeh Sahebdel, Azita Parvaneh Tafreshi, Ehsan Arefian

Pageof 3

Frequent Collaborators

3 joint publications

Masoud Soleimani

1 joint publications

Shiva Irani

1 joint publications

Mehdi Doosti-Telgerd

1 joint publications

Mohammad Porgham Daryasari